How do insurance complexities and medication delays affect Medicare?
Medicare's complexity and new AI pilot may increase red tape for beneficiaries. The case of Kenney Blewett in Texas demonstrated how insurance hurdles can delay critical care, specifically when a prescription interacts with Medicare Part B and a private Part D plan. The delay occurred because the prescription submitted to Medicare Part B was missing a necessary diagnostic code from the physician. Furthermore, Medicare has launched a pilot program in six states, including Texas, testing AI for preapproval, which experts warn is creating more red tape for beneficiaries.
- Effect
- Strong negative
- How direct
- 2 steps, all reported
- When
- Over the long term
- The story
- No new developments lately
How it reaches Medicare
-
In Texas, a patient's prescription for a new medication to treat chronic obstructive pulmonary disease was delayed by Walgreens. Walgreens informed the patient that the delay was due to an insurance issue that the company was working to resolve.
The full event1independent outlet -
Kenney Blewett's prescription for a new COPD medication was delayed at Walgreens because of an insurance issue. The pharmacy attempted to process the prescription through Medicare Part B on June 2, but it was missing a necessary diagnostic code from the physician.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- hanfordsentinel.com Oct 6
-
American pharmacy and convenience store chain
Everything about Walgreens -
The delay highlighted the convoluted nature of Medicare, particularly the distinctions between Part B and Part D plans. Additionally, Medicare is piloting an AI program in six states, including Texas, to preapprove services, a move that physicians and patients say is creating more red tape and leading to inappropriate denials.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- hanfordsentinel.com Oct 6
-
US federal health insurance
Everything about Medicare
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- Kenney Blewett required a new medication for COPD flare-ups, prescribed on June 2.hanfordsentinel.com
- The medication delay occurred because the prescription was submitted to Medicare Part B but was missing a necessary diagnostic code.hanfordsentinel.com
- Medicare launched a pilot program in six states, including Texas, testing the use of AI to preapprove healthcare services.hanfordsentinel.com
- Nearly 7 in 10 adults call insurance delays and denials a major problem, according to a January KFF Health Tracking Poll.hanfordsentinel.com
Why it matters
For Medicare beneficiaries, the complexity of the system directly impacts access to life-saving care. The case of Kenney Blewett shows that administrative hurdles, such as missing diagnostic codes or confusing Part B/Part D distinctions, can lead to critical medication delays, potentially worsening health outcomes.
The introduction of AI into the preapproval process, intended to root out waste, is viewed by many as adding layers of bureaucracy. This systemic complexity is compounded by the fact that most health insurance plans, including traditional Medicare, are not under state jurisdiction, making navigation a 'herculean task' for patients and caregivers.
What we don't know yet
- How will the scope of Medicare's AI preapproval pilot program expand to include more services and states?
- How will the lack of physician response to requests for diagnostic codes affect future claims processing?
Is this still moving?
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
What would change this answer
— Other considerations
Beyond this explainer
Explore connected ideas
Each opens a map of what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Reporting
- hanfordsentinel.comOct 6
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. It is not investment advice; do your own research.